AirSculpt Technologies, Inc. Operating Income
AirSculpt Technologies, Inc. (AIRS) reported Operating Income of -$29.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-10
- AirSculpt Technologies, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$29.00K, a 103.69% decline year-over-year.
- AirSculpt Technologies, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$1.80M.
- AirSculpt Technologies, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$1.01M.
- AirSculpt Technologies, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$9.75M.
- AirSculpt Technologies, Inc. operating income (loss) for fiscal 2025 was -$11.56M.
- AirSculpt Technologies, Inc. operating income (loss) for fiscal 2024 was -$1.58M, a 116.28% decline from fiscal 2023.
- AirSculpt Technologies, Inc. operating income (loss) for fiscal 2023 was $9.72M.
- AirSculpt Technologies, Inc. operating income (loss) for fiscal 2022 was -$4.54M, a 128.82% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$29.00K 10-Q · filed 2026-08-10 | -$1.83M 10-Q · filed 2026-08-10 | -$2.84M derived: sum of 3 quarters · filed 2026-08-10 | -$12.59M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | -$1.80M 10-Q · filed 2026-05-08 | -$2.81M derived: sum of 2 quarters · filed 2026-05-08 | -$12.56M derived: sum of 3 quarters · filed 2026-05-08 | -$11.77M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | -$1.01M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | -$10.76M derived: sum of 2 quarters · filed 2026-04-06 | -$9.97M derived: sum of 3 quarters · filed 2026-08-10 | -$11.56M 10-K/A · filed 2026-04-06 | |
| 2025-09-30 | -$9.75M 10-Q · filed 2025-11-07 | -$8.96M derived: sum of 2 quarters · filed 2026-08-10 | -$10.55M 10-Q · filed 2025-11-07 | -$14.45M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | $786.00K 10-Q · filed 2026-08-10 | -$803.00K 10-Q · filed 2026-08-10 | -$4.70M derived: sum of 3 quarters · filed 2026-08-10 | -$8.42M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | -$1.59M 10-Q · filed 2026-05-08 | -$5.49M derived: sum of 2 quarters · filed 2026-05-08 | -$9.20M derived: sum of 3 quarters · filed 2026-05-08 | -$14.18M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$3.90M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | -$7.61M derived: sum of 2 quarters · filed 2026-04-06 | -$12.60M derived: sum of 3 quarters · filed 2026-04-06 | -$1.58M 10-K/A · filed 2026-04-06 | -$1.82M 10-K · filed 2025-03-14 |
| 2024-09-30 | -$3.72M 10-Q · filed 2025-11-07 | -$8.70M derived: sum of 2 quarters · filed 2025-11-07 | $2.31M 10-Q · filed 2025-11-07 | $3.96M derived: sum of 4 quarters · filed 2026-04-06 | |
| 2024-06-30 | -$4.98M 10-Q · filed 2025-08-01 | $6.03M 10-Q · filed 2025-08-01 | $7.67M derived: sum of 3 quarters · filed 2026-04-06 | $8.63M derived: sum of 4 quarters · filed 2026-04-06 | |
| 2024-03-31 | $11.01M 10-Q · filed 2025-05-02 | $12.65M derived: sum of 2 quarters · filed 2026-04-06 | $13.61M derived: sum of 3 quarters · filed 2026-04-06 | $18.97M derived: sum of 4 quarters · filed 2026-04-06 | |
| 2023-12-31 | $1.64M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | $2.60M derived: sum of 2 quarters · filed 2026-04-06 | $7.96M derived: sum of 3 quarters · filed 2026-04-06 | $9.72M 10-K/A · filed 2026-04-06 | $9.48M 10-K · filed 2024-02-27 |
| 2023-09-30 | $955.00K 10-Q · filed 2024-11-08 | $6.32M derived: sum of 2 quarters · filed 2024-11-08 | $8.08M 10-Q · filed 2024-11-08 | $2.12M derived: sum of 4 quarters · filed 2025-03-14 | |
| 2023-06-30 | $5.36M 10-Q · filed 2024-08-09 | $7.12M 10-Q · filed 2024-08-09 | $1.16M derived: sum of 3 quarters · filed 2025-03-14 | -$213.00K derived: sum of 4 quarters · filed 2025-03-14 | |
| 2023-03-31 | $1.76M 10-Q · filed 2024-05-10 | -$4.20M derived: sum of 2 quarters · filed 2025-03-14 | -$5.58M derived: sum of 3 quarters · filed 2025-03-14 | -$1.61M derived: sum of 4 quarters · filed 2025-03-14 | |
| 2022-12-31 | -$5.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$7.34M derived: sum of 2 quarters · filed 2025-03-14 | -$3.37M derived: sum of 3 quarters · filed 2025-03-14 | -$4.54M 10-K · filed 2025-03-14 | |
| 2022-09-30 | -$1.38M 10-Q · filed 2023-11-13 | $2.59M derived: sum of 2 quarters · filed 2023-11-13 | $1.42M 10-Q · filed 2023-11-13 | -$10.84M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $3.96M 10-Q · filed 2023-08-11 | $2.79M 10-Q · filed 2023-08-11 | -$9.46M derived: sum of 3 quarters · filed 2024-02-27 | $155.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | -$1.17M 10-Q · filed 2023-05-12 | -$13.43M derived: sum of 2 quarters · filed 2024-02-27 | -$3.81M derived: sum of 3 quarters · filed 2024-02-27 | $7.39M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | -$12.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$2.64M derived: sum of 2 quarters · filed 2024-02-27 | $8.56M derived: sum of 3 quarters · filed 2024-02-27 | $15.77M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $9.62M 10-Q · filed 2022-11-14 | $20.82M derived: sum of 2 quarters · filed 2022-11-14 | $28.02M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $11.20M 10-Q · filed 2022-08-12 | $18.41M 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | $7.21M 10-Q · filed 2022-05-13 | ||||
| 2020-12-31 | $10.03M 10-K · filed 2023-03-10 | ||||
| 2019-12-31 | $663.00K 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |